Luzia Mayr

1.3k total citations
23 papers, 610 citations indexed

About

Luzia Mayr is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Luzia Mayr has authored 23 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Virology, 15 papers in Immunology and 10 papers in Infectious Diseases. Recurrent topics in Luzia Mayr's work include HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS Research and Interventions (8 papers). Luzia Mayr is often cited by papers focused on HIV Research and Treatment (19 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS Research and Interventions (8 papers). Luzia Mayr collaborates with scholars based in United States, France and China. Luzia Mayr's co-authors include Milka Sarris, Kristian G. Andersen, Felix Randow, Alexander G. Betz, Christiane Moog, Bin Su, Susan Zolla‐Pazner, Xiang‐Peng Kong, Sandra Cohen and Brett Spurrier and has published in prestigious journals such as Immunity, The Journal of Immunology and PLoS ONE.

In The Last Decade

Luzia Mayr

23 papers receiving 607 citations

Peers

Luzia Mayr
Daniel Byrd United States
Claas Otto Germany
T. Matt Holl United States
K Woods-Cook Switzerland
Nithianandan Selliah United States
Keith E. Nye United Kingdom
Sabrina Imam United States
Christina Ochsenbauer United States
Eric Riedel United States
Daniel Byrd United States
Luzia Mayr
Citations per year, relative to Luzia Mayr Luzia Mayr (= 1×) peers Daniel Byrd

Countries citing papers authored by Luzia Mayr

Since Specialization
Citations

This map shows the geographic impact of Luzia Mayr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luzia Mayr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luzia Mayr more than expected).

Fields of papers citing papers by Luzia Mayr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luzia Mayr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luzia Mayr. The network helps show where Luzia Mayr may publish in the future.

Co-authorship network of co-authors of Luzia Mayr

This figure shows the co-authorship network connecting the top 25 collaborators of Luzia Mayr. A scholar is included among the top collaborators of Luzia Mayr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luzia Mayr. Luzia Mayr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vazquez, Thomas, Fabien Pitoiset, Béatrice Levacher, et al.. (2023). Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity. European Journal of Pharmaceutics and Biopharmaceutics. 191. 124–138. 2 indexed citations
2.
Carapito, Raphaël, Luzia Mayr, Anne Molitor, et al.. (2020). A FcɣRIIa polymorphism has a HLA-B57 and HLA-B27 independent effect on HIV disease outcome. Genes and Immunity. 21(4). 263–268. 6 indexed citations
3.
Liu, Lily, Liuzhe Li, Aubin Nanfack, et al.. (2019). Anti-V2 antibody deficiency in individuals infected with HIV-1 in Cameroon. Virology. 529. 57–64. 7 indexed citations
4.
Su, Bin, Luzia Mayr, Jéromine Klingler, et al.. (2018). HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies. AIDS. 32(10). 1239–1245. 1 indexed citations
5.
Mayr, Luzia, Aubin Nanfack, Michael Tuen, et al.. (2017). Contrasting antibody responses to intrasubtype superinfection with CRF02_AG. PLoS ONE. 12(3). e0173705–e0173705. 18 indexed citations
6.
Mayr, Luzia, Bin Su, & Christiane Moog. (2017). Role of nonneutralizing antibodies in vaccines and/or HIV infected individuals. Current Opinion in HIV and AIDS. 12(3). 209–215. 12 indexed citations
7.
Mayr, Luzia, Bin Su, & Christiane Moog. (2017). Langerhans Cells: the ‘Yin and Yang’ of HIV Restriction and Transmission. Trends in Microbiology. 25(3). 170–172. 16 indexed citations
8.
Mayr, Luzia, Thomas Decoville, Sylvie Schmidt, et al.. (2017). Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity. Scientific Reports. 7(1). 12655–12655. 35 indexed citations
9.
Mayr, Luzia, Bin Su, & Christiane Moog. (2017). Non-Neutralizing Antibodies Directed against HIV and Their Functions. Frontiers in Immunology. 8. 1590–1590. 44 indexed citations
10.
Su, Bin, Maryse Peressin, Luzia Mayr, et al.. (2015). Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection. AIDS Research and Human Retroviruses. 31(11). 1187–1191. 6 indexed citations
11.
Mayr, Luzia & Susan Zolla‐Pazner. (2015). Antibodies Targeting the Envelope of HIV-1. Microbiology Spectrum. 3(1). AID–25. 8 indexed citations
12.
Kumar, Rajnish, Ruimin Pan, Chitra Upadhyay, et al.. (2015). Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL. Journal of Virology. 89(17). 9090–9102. 8 indexed citations
13.
Upadhyay, Chitra, Luzia Mayr, Jing Zhang, et al.. (2014). Distinct Mechanisms Regulate Exposure of Neutralizing Epitopes in the V2 and V3 Loops of HIV-1 Envelope. Journal of Virology. 88(21). 12853–12865. 34 indexed citations
14.
Mayr, Luzia, Sandra Cohen, Brett Spurrier, Xiang‐Peng Kong, & Susan Zolla‐Pazner. (2013). Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2. PLoS ONE. 8(7). e70859–e70859. 37 indexed citations
15.
Agyingi, Lucy, Luzia Mayr, Thompson Kinge, et al.. (2013). The evolution of HIV‐1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutations. Journal of Medical Virology. 86(3). 385–393. 14 indexed citations
16.
Mayr, Luzia, et al.. (2012). Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus. PLoS ONE. 7(6). e38989–e38989. 6 indexed citations
18.
Mayr, Luzia, Rebecca Powell, Thompson Kinge, & Phillipe N. Nyambi. (2011). Sequence Analysis of the Dimerization Initiation Site of Concordant and Discordant Viral Variants Superinfecting HIV Type 1 Patients. AIDS Research and Human Retroviruses. 27(11). 1231–1235. 1 indexed citations
19.
Sarris, Milka, Kristian G. Andersen, Felix Randow, Luzia Mayr, & Alexander G. Betz. (2008). Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition. Immunity. 28(3). 402–413. 280 indexed citations
20.
Malcherek, Georg, Luzia Mayr, Pedro Roda‐Navarro, et al.. (2007). The B7 Homolog Butyrophilin BTN2A1 Is a Novel Ligand for DC-SIGN. The Journal of Immunology. 179(6). 3804–3811. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026